EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimal control of monomers and oligomers degradation in an Alzheimer’s disease model

Iulia Martina Bulai, Francesco Ferraresso, Francesca Gladiali

Journal of Mathematical Biology · 2025

DOI: 10.1007/s00285-025-02256-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Mathematical Biology, 2025. Verfasst von Iulia Martina Bulai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical, Physical, Mathematical and Natural Sciences, Via Vienna 2, 07100, Sassari, Italy. iuliamartina.bulai@unito.it. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Models, Neurological, Models, Biological. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry for Research and Education, Università degli Studi di Sassari.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aggregation and accumulation of oligomers of misfolded A $$\beta$$ -amyloids in the human brain is one of the possible causes for the onset of the Alzheimer’s disease in the early stage. We introduce and study a new ODE model for the evolution of Alzheimer’s disease based on the interaction between monomers, proto-oligomers, and oligomers of A $$\beta$$ amyloid protein in a small portion of the human brain, based upon biochemical processes such as polymerization, depolymerization, fragmentation and concatenation. We further introduce the possibility of controlling the evolution of the system via a treatment that targets the monomers and/or the oligomers. We observe that a combined optimal treatment on both monomers and oligomers induces a substantial decrease of the oligomer concentration at the final stage. A single treatment on oligomers performs better than a single treatment on monomers. These results shed a light on the effectiveness of immunotherapy using anti-A $$\beta$$ antibodies, targeting monomers or oligomers. Several numerical simulations show how the oligomer concentration evolves without treatment, with single monomer/oligomer treatment, or with a combined treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesModels, NeurologicalModels, BiologicalHumansComputer SimulationMathematical ConceptsBrainImmunotherapy

Stichwörter der Autor:innen

Alzheimer diseaseMonomer degradationODEsOligomer degradationOptimal control

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Chemical, Physical, Mathematical and Natural Sciences, Via Vienna 2, 07100, Sassari, Italy. iuliamartina.bulai@unito.it.
  • Department of Mathematics "Giuseppe Peano", University of Torino, via Carlo Alberto 10, 10123, Torino, Italy. iuliamartina.bulai@unito.it.
  • Department of Computer Science, Strada Le Grazie 15, Ca' Vignal 2, 37134, Verona, Italy.
  • Department of Chemical, Physical, Mathematical and Natural Sciences, Via Vienna 2, 07100, Sassari, Italy.

Förderung

  • Italian Ministry for Research and Education
  • Università degli Studi di Sassari

Zitieren

APA

Bulai, I. M., Ferraresso, F., & Gladiali, F. (2025). Optimal control of monomers and oligomers degradation in an Alzheimer’s disease model. Journal of Mathematical Biology. https://doi.org/10.1007/s00285-025-02256-3

Vancouver

Bulai IM, Ferraresso F, Gladiali F. Optimal control of monomers and oligomers degradation in an Alzheimer’s disease model. Journal of Mathematical Biology. 2025. doi:10.1007/s00285-025-02256-3

BibTeX
@article{Bulai2025,
  author = {Bulai, Iulia Martina and Ferraresso, Francesco and Gladiali, Francesca},
  title = {Optimal control of monomers and oligomers degradation in an Alzheimer’s disease model},
  journal = {Journal of Mathematical Biology},
  year = {2025},
  doi = {10.1007/s00285-025-02256-3}
}
Kostenlos starten →